Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis.
Salah Eddin KarimiAzadeh BayaniPeter HiggsAmir-Hossein BayatMorteza HemmatElahe AhounbarBahram ArmoonYadolah FakhriPublished in: Substance abuse treatment, prevention, and policy (2020)
Prevention programs that address age > 30 years, being female, past treatment attempt, previous testing of safe sexual practices, are strongly recommended to prioritize HCV risk reduction strategies.